Trifluoroacetic acid → HCID 118045869, compound
Reaction equation
[NH2:1][C:2]1[C:3]([C:22]2[CH:37]=[CH:36][C:25]([C:26]([NH:28][CH2:29][C:30]3[CH:35]=[CH:34][CH:33]=[CH:32][CH:31]=3)=[O:27])=[C:24]([F:38])[CH:23]=2)=[N:4][C:5]([CH:8]2[CH2:13][CH2:12][CH2:11][CH:10]([O:14][Si](C(C)(C)C)(C)C)[CH2:9]2)=[CH:6][N:7]=1.C(=O)(O)[O-].[Na+].C(O)(C(F)(F)F)=O>Cl.C1COCC1.CO>[NH2:1][C:2]1[C:3]([C:22]2[CH:37]=[CH:36][C:25]([C:26]([NH:28][CH2:29][C:30]3[CH:35]=[CH:34][CH:33]=[CH:32][CH:31]=3)=[O:27])=[C:24]([F:38])[CH:23]=2)=[N:4][C:5]([C@@H:8]2[CH2:13][CH2:12][CH2:11][C@H:10]([OH:14])[CH2:9]2)=[CH:6][N:7]=1Participants
7
Procedure
A mixture of 4-(3-amino-6-(3-((tert-butyldimethylsilyl)oxy)cyclohexyl)pyrazin-2-yl)-N-benzyl-2-fluorobenzamide (61 mg, 0.114 mmol) in 6N HCl (0.29 mL),THF (0. 57 mL) and MeOH (0.285 mL) was stirred for 2 h. Solid sodium bicarbonate was added to neutralize the reaction mixture. Solvent was evaporated and 25% of the residue was dissolved in DMSO, and purified with auto-prep to provide 15 mg of desired cis racemate compound as a TFA salt. LCMS (m/z): 421.3 (MH+), 0.74 min. 1H NMR (400 MHz, MeOD-d4) δ ppm 7.82-7.69 (m, 2H) 7. 62-7. 45 (m, 2H) 7.37-7.12 (m, 5H) 4.52 (s, 2H) 3.66-3.52 (m, 1H) 2.75-2.60 (m, 1H) 2.11-2.01 (m, 1H) 1.97-1.70 (m, 3H) 1.52-1.29 (m, 3H) 1.24-1.08 (m, 1H).
Workup
- customSolvent was evaporated
- dissolution25% of the residue was dissolved in DMSO
- custompurified with auto-prep
- customto provide 15 mg
- custom421.3 (MH+), 0.74 min
Sources & evidence
- ORD record
- ord-d6f5c15d88c64cd698b2e92f3a597a35
- Source dataset
- uspto-grants-2016_01
- Patent number
- US09242996B2
Reaction notes
Loading…